Our complete solutions

Ergomed uses its leading expertise in the co-development of drugs to offer a complete, global Phase I-IV clinical development and trial management service.

Explore Our Process

To navigate, click each section and read more about our services and expertise.

Therapeutic Expertise

Phase I

Phase II

Phase III

Phase IV

Phase I

Ergomed offers a combination of expert skills and excellent resources. Our experts in early development have extensive experience in clinical pharmacology and clinical trial design, development, and execution particularly in oncology and rare diseases where the standard approaches are not fit for purpose.

We also partner with top investigators in some of the best phase I units in Europe and North America. This combination allows us to anticipate and remove any factors that could impact your early stage development.

Phase II

Proving the efficacy of a medicine in Phase II clinical trials is an extremely sensitive part of drug development.

Management of Phase II trials requires highly experienced people who are able to identify potential challenges, mitigate risks, engage top investigators, recruit the right patients, and design a trial that will truly evaluate your candidate.

Phase III

Late-stage clinical trials require both know-how and an extensive network. Our teams regularly navigate the challenges of recruiting huge patient populations whilst also meeting clinical standards and regulatory requirements.

They also regularly manage the complexities of Phase III trials, operating across multiple time zones, languages, cultures, and working environments.

Phase IV

Phase IV solutions ensure that your medicine’s full potential is recognized. With over 30 years of experience in this area, we have deep expertise across a wide range of therapeutic areas.

As Phase IV trials increasingly embrace advanced technologies, our teams have the experience to credibly establish evidence of value in real-world-settings.

Our background in co-development means we understand what it takes to deliver drugs to market quickly and responsibly.
0 offices worldwide
0 countries with active clinical trials
0 EU QPPV projects
0 professionals
0 years' experience
0 oncology studies
0 rare disease studies
0 studies completed
Discover how we can help you

This site uses cookies to personalize and customize your experience. By clicking “I Accept", you consent to cookies in accordance with our privacy policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services
Secured By miniOrange